AllSquare Wealth Management LLC Sells 205 Shares of CVS Health Corporation (CVS)
AllSquare Wealth Management LLC decreased its holdings in CVS Health Corporation (NYSE:CVS) by 8.4% in the second quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor owned 2,232 shares of the pharmacy operator’s stock after selling 205 shares during the quarter. AllSquare Wealth Management LLC’s holdings in CVS Health Corporation were worth $180,000 as of its most recent filing with the SEC.
Several other hedge funds have also made changes to their positions in CVS. TB Alternative Assets Ltd. acquired a new stake in shares of CVS Health Corporation during the 2nd quarter worth about $121,000. Gemmer Asset Management LLC increased its position in shares of CVS Health Corporation by 15.3% during the 2nd quarter. Gemmer Asset Management LLC now owns 1,509 shares of the pharmacy operator’s stock worth $121,000 after purchasing an additional 200 shares in the last quarter. SRS Capital Advisors Inc. increased its position in shares of CVS Health Corporation by 48.2% during the 1st quarter. SRS Capital Advisors Inc. now owns 2,256 shares of the pharmacy operator’s stock worth $177,000 after purchasing an additional 734 shares in the last quarter. Grace & White Inc. NY acquired a new stake in shares of CVS Health Corporation during the 2nd quarter worth about $199,000. Finally, Nadler Financial Group Inc. acquired a new stake in shares of CVS Health Corporation during the 2nd quarter worth about $202,000. Institutional investors own 81.46% of the company’s stock.
ILLEGAL ACTIVITY WARNING: “AllSquare Wealth Management LLC Sells 205 Shares of CVS Health Corporation (CVS)” was first published by Watch List News and is owned by of Watch List News. If you are accessing this news story on another site, it was illegally copied and reposted in violation of international trademark & copyright legislation. The correct version of this news story can be viewed at https://www.watchlistnews.com/allsquare-wealth-management-llc-sells-205-shares-of-cvs-health-corporation-cvs/1684414.html.
CVS Health Corporation (NYSE CVS) opened at $66.80 on Tuesday. The company has a current ratio of 1.09, a quick ratio of 0.56 and a debt-to-equity ratio of 0.75. CVS Health Corporation has a 52-week low of $66.57 and a 52-week high of $84.72. The company has a market cap of $70,397.13, a price-to-earnings ratio of 11.84, a price-to-earnings-growth ratio of 1.26 and a beta of 0.86.
CVS Health Corporation (NYSE:CVS) last released its quarterly earnings data on Monday, November 6th. The pharmacy operator reported $1.50 EPS for the quarter, topping the Zacks’ consensus estimate of $1.49 by $0.01. CVS Health Corporation had a net margin of 2.93% and a return on equity of 17.47%. The firm had revenue of $46.18 billion during the quarter, compared to analysts’ expectations of $46.17 billion. During the same period in the previous year, the business posted $1.64 earnings per share. The company’s revenue for the quarter was up 3.5% compared to the same quarter last year. equities analysts predict that CVS Health Corporation will post 5.88 EPS for the current year.
The firm also recently announced a quarterly dividend, which was paid on Friday, November 3rd. Stockholders of record on Tuesday, October 24th were given a $0.50 dividend. The ex-dividend date of this dividend was Monday, October 23rd. This represents a $2.00 dividend on an annualized basis and a dividend yield of 2.99%. CVS Health Corporation’s payout ratio is presently 39.92%.
A number of brokerages have commented on CVS. Citigroup Inc. decreased their price objective on shares of CVS Health Corporation from $87.00 to $74.00 and set a “neutral” rating on the stock in a report on Friday. TheStreet lowered shares of CVS Health Corporation from a “b-” rating to a “c+” rating in a report on Tuesday, October 31st. Cowen and Company set a $86.00 price objective on shares of CVS Health Corporation and gave the stock a “buy” rating in a report on Sunday, October 29th. Loop Capital reissued a “hold” rating on shares of CVS Health Corporation in a report on Friday, October 27th. Finally, Robert W. Baird reissued a “hold” rating and set a $77.00 price objective on shares of CVS Health Corporation in a report on Friday, October 27th. One investment analyst has rated the stock with a sell rating, nine have assigned a hold rating and fifteen have assigned a buy rating to the stock. CVS Health Corporation has an average rating of “Buy” and a consensus price target of $87.33.
In other news, EVP Thomas M. Moriarty sold 90,267 shares of the business’s stock in a transaction dated Monday, September 11th. The shares were sold at an average price of $79.61, for a total value of $7,186,155.87. Following the completion of the sale, the executive vice president now owns 70,102 shares of the company’s stock, valued at $5,580,820.22. The sale was disclosed in a document filed with the SEC, which is available at this hyperlink. Also, Director Richard J. Swift sold 2,500 shares of the business’s stock in a transaction dated Wednesday, August 16th. The shares were sold at an average price of $79.62, for a total transaction of $199,050.00. Following the completion of the sale, the director now directly owns 3,258 shares of the company’s stock, valued at approximately $259,401.96. The disclosure for this sale can be found here. In the last three months, insiders sold 716,625 shares of company stock valued at $58,318,431. 0.61% of the stock is currently owned by company insiders.
About CVS Health Corporation
CVS Health Corporation, together with its subsidiaries, is an integrated pharmacy healthcare company. The Company provides pharmacy care for the senior community through Omnicare, Inc (Omnicare) and Omnicare’s long-term care (LTC) operations, which include distribution of pharmaceuticals, related pharmacy consulting and other ancillary services to chronic care facilities and other care settings.
Want to see what other hedge funds are holding CVS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for CVS Health Corporation (NYSE:CVS).
Receive News & Ratings for CVS Health Corporation Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CVS Health Corporation and related companies with Analyst Ratings Network's FREE daily email newsletter.